Issue navigation
Volume 72, Issue 2, February 2017
Reviews
Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 323–329, https://doi.org/10.1093/jac/dkw494
Antibiotic resistance among Ureaplasma spp. isolates: cause for concern?
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 330–337, https://doi.org/10.1093/jac/dkw425
Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 338–353, https://doi.org/10.1093/jac/dkw426
Linezolid: a promising option in the treatment of Gram-positives
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 354–364, https://doi.org/10.1093/jac/dkw450
Systematic review
Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 365–371, https://doi.org/10.1093/jac/dkw463
Original research
MRSA infections among patients in the emergency department: a European multicentre study
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 372–375, https://doi.org/10.1093/jac/dkw431
Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 376–384, https://doi.org/10.1093/jac/dkw466
A sampling and metagenomic sequencing-based methodology for monitoring antimicrobial resistance in swine herds
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 385–392, https://doi.org/10.1093/jac/dkw415
Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 393–401, https://doi.org/10.1093/jac/dkw411
IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 402–406, https://doi.org/10.1093/jac/dkw435
Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: implications for antimicrobial resistance surveillance?
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 407–409, https://doi.org/10.1093/jac/dkw406
Analysis of linezolid and tigecycline as candidates for local prophylaxis via antibiotic-loaded bone cement
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 410–416, https://doi.org/10.1093/jac/dkw410
In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 417–420, https://doi.org/10.1093/jac/dkw427
Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 421–427, https://doi.org/10.1093/jac/dkw421
In vitro ‘time-to-kill’ assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 428–430, https://doi.org/10.1093/jac/dkw409
Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 431–436, https://doi.org/10.1093/jac/dkw442
Phenotypic detection of the cfiA metallo-β-lactamase in Bacteroides fragilis with the meropenem–EDTA double-ended Etest and the ROSCO KPC/MBL Confirm Kit
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 437–440, https://doi.org/10.1093/jac/dkw436
In vitro activity of daptomycin combined with dalbavancin and linezolid, and dalbavancin with linezolid against MRSA strains
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 441–443, https://doi.org/10.1093/jac/dkw416
In vitro activity of gentamicin as an adjunct to penicillin against biofilm group B Streptococcus
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 444–447, https://doi.org/10.1093/jac/dkw447
Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 448–454, https://doi.org/10.1093/jac/dkw456
Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 455–461, https://doi.org/10.1093/jac/dkw417
Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 462–466, https://doi.org/10.1093/jac/dkw433
Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 467–477, https://doi.org/10.1093/jac/dkw448
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 478–485, https://doi.org/10.1093/jac/dkw412
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 486–489, https://doi.org/10.1093/jac/dkw429
Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 490–495, https://doi.org/10.1093/jac/dkw444
Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 496–503, https://doi.org/10.1093/jac/dkw455
Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014–15
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 504–510, https://doi.org/10.1093/jac/dkw445
Impact of polypharmacy on antiretroviral prescription in people living with HIV
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 511–514, https://doi.org/10.1093/jac/dkw437
Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 515–521, https://doi.org/10.1093/jac/dkw428
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 522–528, https://doi.org/10.1093/jac/dkw499
Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 529–534, https://doi.org/10.1093/jac/dkw424
Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 535–542, https://doi.org/10.1093/jac/dkw453
Development of operationalized intravenous to oral antibiotic switch criteria
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 543–546, https://doi.org/10.1093/jac/dkw470
Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 547–553, https://doi.org/10.1093/jac/dkw441
Variability in antibiotic use across Ontario acute care hospitals
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 554–563, https://doi.org/10.1093/jac/dkw454
A community survey of antibiotic consumption among children in Madagascar and Senegal: the importance of healthcare access and care quality
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 564–573, https://doi.org/10.1093/jac/dkw446
Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 574–581, https://doi.org/10.1093/jac/dkw423
Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 582–588, https://doi.org/10.1093/jac/dkw419
ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 589–595, https://doi.org/10.1093/jac/dkw443
Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 596–603, https://doi.org/10.1093/jac/dkw414
Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17)
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 604–613, https://doi.org/10.1093/jac/dkw434
Research letters
Retrospective analysis of genome sequences revealed the wide dissemination of optrA in Gram-positive bacteria
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 614–616, https://doi.org/10.1093/jac/dkw488
Increasing resistance to fusidic acid among clinical isolates of MRSA
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 616–618, https://doi.org/10.1093/jac/dkw430
A case of multiple contamination with methylase ArmA-producing pathogens
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 618–620, https://doi.org/10.1093/jac/dkw418
Genomic islands 1 and 2 carry multiple antibiotic resistance genes in Pseudomonas aeruginosa ST235, ST253, ST111 and ST175 and are globally dispersed
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 620–622, https://doi.org/10.1093/jac/dkw471
Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 622–624, https://doi.org/10.1093/jac/dkw451
Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 624–625, https://doi.org/10.1093/jac/dkw405
Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 625–628, https://doi.org/10.1093/jac/dkw484
Acute reversible pancreatitis induced by posaconazole
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 628–630, https://doi.org/10.1093/jac/dkw465
HIV-1 diagnosis with unquantifiable viraemia: don’t be naive, look for antiretroviral drugs
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 630–632, https://doi.org/10.1093/jac/dkw474
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 632–633, https://doi.org/10.1093/jac/dkw439
Letters to the Editor
Comment on: Resistance gene naming and numbering: is it a new gene or not?
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 634–637, https://doi.org/10.1093/jac/dkw407
Resistance gene naming and numbering: is it a new gene or not?—authors' response
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Page 635, https://doi.org/10.1093/jac/dkw440
Comment on: Benchmarking of methods for identification of antimicrobial resistance genes in bacterial whole genome data
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 635–636, https://doi.org/10.1093/jac/dkw473
Comment on: Transferable resistance to colistin: a new but old threat
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 636–637, https://doi.org/10.1093/jac/dkw432
